Asieris CEO to Host CEO Roundtable at Upcoming WuXi Healthcare Forum 2019

SHANGHAI, China, March 1, 2019 – Asieris Pharmaceuticals, a clinical-stage biopharmaceutical company, announced today that Dr. Kevin Pan, the company CEO, will host a CEO Roundtable at 4:00pm on March 6 at the WuXi Healthcare Forum 2019 in Shanghai, China. The Roundtable will commence with an introduction of Asieris, including the company’s R&D strategies, management team, product pipeline, and leading drug candidates currently under global clinical development. based on the interest of the attendees, discussion will cover such hot topics as China-US dual NDA submission, discovery and development of first-in-class oncology drugs, and cross-border partnership.

For more details about the WuXi Healthcare Forum 2019, please visit the website at:
[Archived link no longer working] https://www.wuximediaglobal.com/announcing-latest-agenda-for-wuxi-healthcare-forum-2019/.

About Asieris Pharmaceuticals
Asieris Pharmaceuticals is a science-driven biotech company dedicated to the discovery and development of innovative therapies in oncology, with a China commercial focus on urology and women’s health. Founded in 2010, Asieris currently has operations in Shanghai, Beijing, Taizhou of Jiangsu Province, and the United States.

This site is registered on wpml.org as a development site.